Mental disorders represent a worldwide public health concern. Psychotherapies and
pharmacotherapies are recommended as first line treatments. However, evidence has …

Tobacco smoking is a major determinant of preventable morbidity and mortality worldwide.
More than a billion people smoke, and without major increases in cessation, at least half will …

Individuals with substance use disorders (SUDs) are at increased risk for COVID‐19
infection and for adverse outcomes of the infection. Though vaccines are highly effective …

Alcohol use disorder (AUD) is a highly prevalent but severely under-treated disorder, with
only three widely-approved pharmacotherapies. Given that AUD is a very heterogeneous …

Despite a growing literature on the complex bidirectional relationship of ADHD and
substance use, reviews specifically focusing on alcohol are scarce. ADHD and AUD show a …

Introduction Smoking and vaping throughout adolescence and early adulthood lead to
nicotine dependence. Nicotine withdrawal is associated with somatic and affective …

Background This study aimed to identify targeted interventions for the prevention and
treatment of harmful alcohol use. Umbrella review methodology was used to summarise the …

Substance dependence represents a pervasive global concern within the realm of public
health. Presently, it is delineated as a persistent and recurrent neurological disorder …

The N-terminal portion of the octapeptide angiotensin II (DRVYIHPF; AngII), a vasopressor
peptide that favorably binds to, and activates, AngII type 1 receptor (AT1R), has an important …

Tobacco smoking is a risk factor for countless diseases, and smoking relapse remains a
major public health concern. Subjective reports of stress by smokers are a common theme …